New research highlights the benefits of combining ARNI, β blockers, MRA, and SGLT2 inhibitors for #HFrEF patients. This regimen could significantly extend event-free survival and overall survival. Discover the full findings: ow.ly/2gon50SBGNi #Cardiology #HeartFailure

Hyperkalemia in heart failure patients on RAASi therapy is challenging, especially with diabetes. Tune in to hear Drs. Bayés-Genís & Rossignol discuss treatment options: ow.ly/GwKb50SGjfN #HeartFailure #CME #Hyperkalemia

Iron deficiency is common in heart failure and can worsen outcomes. A recent study demonstrates the effectiveness of increased screening and IV iron therapy. Explore the results: ow.ly/CFUM50SGjhE #HeartFailure #IronDeficiency #MedicalEducation

Did you know iron deficiency affects over 50% of heart failure patients? Discover the latest treatment recommendations and their impact on patient outcomes. Listen now: ow.ly/36Xi50SQ6mO #HeartHealth #IronDeficiency

Iron deficiency in heart failure can worsen symptoms, reduce exercise capacity, and increase hospitalizations. Screening and treatment are vital. Learn more: ow.ly/yuuz50SQ6rA #HeartHealth #IronDeficiency

Iron deficiency in heart failure patients can lead to reduced survival and functional capacity. Discover the latest clinical evidence on IV iron treatments with Dr. Stefan Anker and other experts: ow.ly/tKwE50ST5PR #HeartFailure #MedicalLearning #CME #IronTherapy

Skeletal muscle dysfunction in heart failure patients impacts exercise capacity and dyspnea. Learn how IV iron supplementation can enhance muscle performance and quality of life: ow.ly/JCcQ50ST5TZ #HeartFailure #IronDeficiency #MedicalResearch #ExerciseCapacity

What’s the latest evidence on IV iron in #HeartFailure treatment? Experts share recent updates to ESC guidelines and provide analysis on clinical trials in this #CME activity: ow.ly/4mKb50SW2xm #MedEd #Cardiology #HeartHealth

How do new potassium binders impact RAASi use in #HeartFailure patients? Dive into this systematic review and meta-analysis on their safety and efficacy: ow.ly/3UgP50SW2Ah #Cardiology #MedicalResearch #PotassiumBinders

How does hyperkalemia impact the use of RAASi in heart failure? Discover expert insights on optimizing HFrEF management with potassium binders: ow.ly/SKMX50SZGbS #Cardiology #Nephrology #CME

Iron deficiency in heart failure patients is often underrecognized. This study covers targeted interventions, enhanced screening, and updated treatment practices for IV iron in heart failure patients. Check it out here: ow.ly/Pgn550SZGh2 #HeartFailure #IronDeficiency

Hyperkalemia in CKD and heart failure patients presents unique challenges. Dr. Ellie Kelepouris and Dr. Stephen Greene discuss guideline-directed therapies and the role of potassium binders. Tune in now: ow.ly/Szwt50T56H5 #Nephrology #Cardiology #Hyperkalemia

How do hierarchical endpoints offer a more holistic view of patient outcomes in heart failure? Discover insights from the HEART-FID trial: ow.ly/XvMz50T56Kr #HeartFailure #Cardiology #HEARTFID

Discover a multidisciplinary approach to hyperkalemia management in CKD and heart failure. Discover insights from nephrology and cardiology experts: ow.ly/9to550TeJkY #HeartFailure #CKD #Hyperkalemia #CMEonReachMD

Current HF guidelines recommend IV iron replacement for patients with reduced ejection fraction and #irondeficiency. Learn about best practices for implementation and discover strategies for overcoming barriers to treatment: ow.ly/Pqyu50TeJmq #HeartFailure #IVIron

How are clinical trials shaping our understanding of intravenous iron for heart failure? Discover comprehensive insights from Drs. Anker, Ponikowski, and Cleland: ow.ly/8t0750Thx68 #HeartFailure #MedEd

Retrospective data shows iron deficiency impacts RV function in cardiac amyloidosis patients. Dive into this research to understand the role of TSAT in patient management: ow.ly/aGiq50ThxaJ #IronDeficiency #Cardiology #CME #HeartFailure

How can we better manage hyperkalemia in heart failure? Explore the role of potassium binders like patiromer in optimizing GDMT and improving outcomes in HFrEF: ow.ly/rLkI50Tonih #HeartFailure #Hyperkalemia #CME

Enabling Medical Therapy for Heart Failure and Overcoming #Hyperkalemia For the #HF community, new tools bring a new reality for hyperK and getting our patients on best #GDMTworks. JACC Journals Shahzeb Khan Aferdita Spahillari Duke Clinical Research Institute authors.elsevier.com/a/1jpbg2d9GH%7…

Despite advancements in HF treatments, patients with CKD often face barriers to receiving life-saving therapies. Discover insights on overcoming these obstacles to care: ow.ly/PwvW50ToovG #HeartFailure #CKDManagement #ClinicalEvidence